HOW DOES UrgoTouch® WORK?

UrgoTouch® is a laser technology that :

  • Decreases the scars volume by up to 53%.**
  • Can be used on all skin phototypes (I to VI)
  • Requires 1 single session in the operating room at the end of any body surgery.*

Why is the scarring process result very unpredictable and random?

The scarring process takes place in 4 main phases in which growth factors (proteins that stimulate the growth of specific tissues) play a key role in organizing the healing process and orchestrating the recovery of the skin. It notably instructs other types of cells to start the production of collagen.

In order to obtain a aesthetic and sufficiently elastic scar, the molecular concentration must be appropriately regulated to ensure a good balance between the synthesis of :

  • Type I collagen: thicker, more rigid
  • Type III collagen: thinner, more flexible, essential to aesthetics and elasticity of the scar

If the mollecular concentration is not balanced, the production of Collagen Type I will overpower Collagene Type III, resulting in a more fibrotic and less elastic scar, and in a risk of having an unaesthetic and problematic scar.

How does UrgoTouch® optimize the scarring process?

UrgoTouch® induces a 50°C temperature on the suture to safely activate Heat shock protein HSP70, which protects skin cells from damages caused by overly high temperatures.

Experimental studies demonstrated that HSP70 could play a role in the modulation of the inflammatory reponse. Thus it may reduce the production of type I collagen as well as inflammatory molecules, leading to improved healing results for patients.***

UrgoTouch® optimizes the scar by reducing the randomness in the healing process associated with this molecular pathway.

*Contraindication for face and cancer

**A 1 Year Follow-up of Post-operative Scars After the Use of a 1210nm Laser Assisted Skin Healing (LASH) Technology: A Randomized Controlled Trial. D.Casanova, ed. Aesthetic Plastic Surgery Journal. Feb 2017 – Reduction of 53% observed in a patient with dark phototype


***Mordon S, Capon A, et al. Lasers thermiques et cicatrisation cutanée. Med Sci (Paris). 2010 Jan